Medical Engineering & Technology Inc is categorized under Health Services in New York City, NY and active since 2009.
Medical Engineering & Technology Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Menji Indar at the company’s single location by writing to 40 Exchange Place, New York City, New York NY 10005 or by phoning (212) 363-8000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Engineering & Technology Inc |
| Contact Person: | Menji Indar |
| Address: | 40 Exchange Place, New York City, New York 10005 |
| Phone Number: | (212) 363-8000 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Medical Engineering & Technology Inc was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Menji Indar for inquiries that concern Medical Engineering & Technology Inc by calling the company number (212) 363-8000, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Engineering & Technology Inc can be found at the coordinates 40.705723,-74.010103 as well as the street address 40 Exchange Place in New York City, New York 10005.
For its online presence, you may visit Medical Engineering & Technology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.